Hutchmed China to shift strategy toward advanced assets in p

Hutchmed Ltd announced on Tuesday it will shift focus towards its most advanced assets from its internal developed pipeline, following an evaluation of the business.

The biopharmaceutical company... | November 15, 2022

Related Keywords

China , Michael Shi , Greg Rosenvinge , Marek Kania , Weigo Su , Alliance News , Head Of Research Development , Hutchmed China Ltd , Chief Medical Officer , China Michael Shi , All Rights , Hutchmed China Limited Stock Exchange , News , Information , Press Release , Hutchmed , Td , Nnounced , N , Tuesday , It , Hill , Shift , Focus , Cowards , Its , Most , Dvanced , Assets , Rom , Internal , Eveloped , Following , Evaluation , F , The , Iopharmaceutical Hcm Kyg4672n1198 ,